Amit Hazan
Stock Analyst at Goldman Sachs
(2.74)
# 1,172
Out of 4,482 analysts
82
Total ratings
56.25%
Success rate
1.33%
Average return
Main Sectors:
23 Stocks
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
INSP Inspire Medical Systems | Upgrades: Buy | n/a | $133.94 | - | 2 | Dec 13, 2022 | |
BVS Bioventus | Maintains: Neutral | $13 → $2.5 | $5.89 | -57.56% | 5 | Nov 30, 2022 | |
SKIN The Beauty Health Company | Maintains: Buy | $22 → $19 | $1.95 | +874.36% | 4 | Nov 23, 2022 | |
SHC Sotera Health Company | Maintains: Neutral | $9 → $8 | $11.65 | -31.33% | 4 | Nov 23, 2022 | |
LIVN LivaNova | Maintains: Buy | $73 → $63 | $52.79 | +19.34% | 3 | Nov 23, 2022 | |
BDX Becton, Dickinson and Company | Maintains: Buy | $319 → $272 | $228.84 | +18.86% | 7 | Nov 23, 2022 | |
BLCO Bausch + Lomb | Maintains: Neutral | $19 → $17 | $14.66 | +15.96% | 3 | Nov 23, 2022 | |
OM Outset Medical | Maintains: Buy | $34 → $29 | $3.84 | +655.21% | 2 | Nov 9, 2022 | |
PRCT PROCEPT BioRobotics | Maintains: Neutral | $39 → $44 | $63.62 | -30.84% | 2 | Nov 4, 2022 | |
EW Edwards Lifesciences | Maintains: Neutral | $97 → $73 | $91.08 | -19.85% | 2 | Nov 3, 2022 | |
BAX Baxter International | Maintains: Sell | $60 → $53 | $33.16 | +59.83% | 10 | Nov 3, 2022 | |
ENOV Enovis | Initiates: Buy | $57 | $44.44 | +28.26% | 1 | Oct 11, 2022 | |
AFIB Acutus Medical | Maintains: Neutral | $1 → $1.5 | $0.03 | +4,587.50% | 3 | Aug 16, 2022 | |
ATEC Alphatec Holdings | Maintains: Neutral | $11 → $9.5 | $9.98 | -4.81% | 2 | Aug 8, 2022 | |
ABT Abbott Laboratories | Maintains: Sell | $111 → $104 | $102.33 | +1.63% | 7 | Jul 25, 2022 | |
TXG 10x Genomics | Maintains: Neutral | $80 → $60 | $18.75 | +220.00% | 2 | Jul 14, 2022 | |
MDT Medtronic | Maintains: Neutral | $129 → $115 | $77.17 | +49.02% | 5 | Jan 18, 2022 | |
SYK Stryker | Downgrades: Sell | n/a | $332.02 | - | 2 | Apr 1, 2020 | |
BSX Boston Scientific | Initiates: Neutral | n/a | $76.11 | - | 1 | Feb 13, 2020 | |
ISRG Intuitive Surgical | Initiates: Buy | n/a | $434.81 | - | 6 | Feb 13, 2020 | |
ZBH Zimmer Biomet Holdings | Initiates: Buy | n/a | $106.58 | - | 2 | Feb 13, 2020 | |
JNJ Johnson & Johnson | Maintains: Neutral | n/a | $145.69 | - | 6 | Feb 25, 2019 | |
ARAY Accuray | Upgrades: Neutral | n/a | $1.73 | - | 1 | Nov 1, 2018 |
Inspire Medical Systems
Dec 13, 2022
Upgrades: Buy
Price Target: n/a
Current: $133.94
Upside: -
Bioventus
Nov 30, 2022
Maintains: Neutral
Price Target: $13 → $2.5
Current: $5.89
Upside: -57.56%
The Beauty Health Company
Nov 23, 2022
Maintains: Buy
Price Target: $22 → $19
Current: $1.95
Upside: +874.36%
Sotera Health Company
Nov 23, 2022
Maintains: Neutral
Price Target: $9 → $8
Current: $11.65
Upside: -31.33%
LivaNova
Nov 23, 2022
Maintains: Buy
Price Target: $73 → $63
Current: $52.79
Upside: +19.34%
Becton, Dickinson and Company
Nov 23, 2022
Maintains: Buy
Price Target: $319 → $272
Current: $228.84
Upside: +18.86%
Bausch + Lomb
Nov 23, 2022
Maintains: Neutral
Price Target: $19 → $17
Current: $14.66
Upside: +15.96%
Outset Medical
Nov 9, 2022
Maintains: Buy
Price Target: $34 → $29
Current: $3.84
Upside: +655.21%
PROCEPT BioRobotics
Nov 4, 2022
Maintains: Neutral
Price Target: $39 → $44
Current: $63.62
Upside: -30.84%
Edwards Lifesciences
Nov 3, 2022
Maintains: Neutral
Price Target: $97 → $73
Current: $91.08
Upside: -19.85%
Baxter International
Nov 3, 2022
Maintains: Sell
Price Target: $60 → $53
Current: $33.16
Upside: +59.83%
Enovis
Oct 11, 2022
Initiates: Buy
Price Target: $57
Current: $44.44
Upside: +28.26%
Acutus Medical
Aug 16, 2022
Maintains: Neutral
Price Target: $1 → $1.5
Current: $0.03
Upside: +4,587.50%
Alphatec Holdings
Aug 8, 2022
Maintains: Neutral
Price Target: $11 → $9.5
Current: $9.98
Upside: -4.81%
Abbott Laboratories
Jul 25, 2022
Maintains: Sell
Price Target: $111 → $104
Current: $102.33
Upside: +1.63%
10x Genomics
Jul 14, 2022
Maintains: Neutral
Price Target: $80 → $60
Current: $18.75
Upside: +220.00%
Medtronic
Jan 18, 2022
Maintains: Neutral
Price Target: $129 → $115
Current: $77.17
Upside: +49.02%
Stryker
Apr 1, 2020
Downgrades: Sell
Price Target: n/a
Current: $332.02
Upside: -
Boston Scientific
Feb 13, 2020
Initiates: Neutral
Price Target: n/a
Current: $76.11
Upside: -
Intuitive Surgical
Feb 13, 2020
Initiates: Buy
Price Target: n/a
Current: $434.81
Upside: -
Zimmer Biomet Holdings
Feb 13, 2020
Initiates: Buy
Price Target: n/a
Current: $106.58
Upside: -
Johnson & Johnson
Feb 25, 2019
Maintains: Neutral
Price Target: n/a
Current: $145.69
Upside: -
Accuray
Nov 1, 2018
Upgrades: Neutral
Price Target: n/a
Current: $1.73
Upside: -